CVS Health Corporation Company Profile (NYSE:CVS)

About CVS Health Corporation

CVS Health Corporation logoCVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise, including over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, photo finishing, seasonal merchandise and greeting cards through the Company's retail stores, online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company, through its wholly owned subsidiary, Omnicare, Inc., provides pharmacy services to long term care facilities.

Industry, Sector and Symbol:
  • Sector: Retail/Wholesale
  • Industry: Health Care Plans
  • Sub-Industry: Drug Retail
  • Exchange: NYSE
  • Symbol: CVS
  • CUSIP: 12665010
Key Metrics:
  • Previous Close: $90.56
  • 50 Day Moving Average: $93.82
  • 200 Day Moving Average: $97.71
  • 52-Week Range: $86.50 - $106.67
  • Trailing P/E Ratio: 20.83
  • Foreward P/E Ratio: 13.76
  • P/E Growth: 1.06
  • Market Cap: $96.56B
  • Outstanding Shares: 1,066,214,000
  • Beta: 0.84
  • Net Margins: 2.88%
  • Return on Equity: 15.86%
  • Return on Assets: 6.20%
  • Debt-to-Equity Ratio: 0.74%
  • Current Ratio: 1.11%
  • Quick Ratio: 0.57%
Additional Links:
Companies Related to CVS Health Corporation:

Analyst Ratings

Consensus Ratings for CVS Health Corporation (NYSE:CVS) (?)
Ratings Breakdown: 4 Hold Ratings, 17 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 2.86)
Consensus Price Target: $113.78 (25.64% upside)

Analysts' Ratings History for CVS Health Corporation (NYSE:CVS)
DateFirmActionRatingPrice TargetDetails
9/20/2016Credit Suisse Group AGReiterated RatingBuy$115.00View Rating Details
9/12/2016Morgan StanleyReiterated RatingHold$104.00View Rating Details
8/8/2016Citigroup Inc.Lower Price TargetNeutral$115.00 -> $108.00View Rating Details
8/4/2016ArgusReiterated RatingBuy$120.00View Rating Details
8/4/2016MizuhoBoost Price TargetBuy$108.00 -> $111.00View Rating Details
8/3/2016Leerink SwannReiterated RatingBuyView Rating Details
8/3/2016Deutsche Bank AGBoost Price TargetHold$99.00 -> $108.00View Rating Details
8/3/2016FBR & CoReiterated RatingOutperform$120.00View Rating Details
7/4/2016Jefferies GroupReiterated RatingBuyView Rating Details
5/5/2016MacquarieReiterated RatingOutperform$115.00View Rating Details
5/4/2016Royal Bank Of CanadaReiterated RatingOutperform$110.00 -> $115.00View Rating Details
3/10/2016Barclays PLCBoost Price TargetOverweight$110.00 -> $115.00View Rating Details
2/10/2016GuggenheimLower Price TargetBuy$120.00 -> $115.00View Rating Details
2/10/2016Goldman Sachs Group Inc.Boost Price TargetNeutral$106.00 -> $110.00View Rating Details
2/3/2016Atlantic SecuritiesInitiated CoverageOverweight$114.00View Rating Details
1/22/2016Robert W. BairdInitiated CoverageOutperform$108.00View Rating Details
12/18/2015Oppenheimer Holdings Inc.Reiterated RatingBuyView Rating Details
11/3/2015S&P Equity ResearchUpgradeStrong-Buy$121.00View Rating Details
11/2/2015Raymond James Financial Inc.Boost Price TargetOutperform$105.00 -> $110.00View Rating Details
11/2/2015BMO Capital MarketsBoost Price TargetOutperform$103.00 -> $113.00View Rating Details
11/2/2015JPMorgan Chase & Co.Lower Price TargetOverweight$128.00 -> $123.00View Rating Details
10/30/2015Evercore ISILower Price TargetBuy$111.00 -> $110.00View Rating Details
10/21/2015Cowen and CompanyLower Price Target$118.00 -> $113.00View Rating Details
2/11/2015Cantor FitzgeraldReiterated RatingHold$83.00View Rating Details
2/10/2015Noble FinancialReiterated RatingOutperformView Rating Details
1/21/2015StephensInitiated CoverageOverweightView Rating Details
1/2/2015Bank of America Corp.Set Price TargetBuy$94.00 -> $104.00View Rating Details
12/19/2014SunTrust Banks Inc.UpgradeNeutral -> Buy$92.00 -> $110.00View Rating Details
(Data available from 9/28/2014 forward)


Earnings History for CVS Health Corporation (NYSE:CVS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/2/2016Q216$1.30$1.32$44.28 billion$43.70 billionViewN/AView Earnings Details
5/3/2016Q116$1.16$1.18$43.01 billion$43.20 billionViewN/AView Earnings Details
2/9/2016Q415$1.53$1.53$41.12 billion$41.15 billionViewN/AView Earnings Details
10/30/2015Q315$1.29$1.28$37.81 billion$38.50 billionViewListenView Earnings Details
8/4/2015Q215$1.20$1.22$37.18 billion$37.20 billionViewN/AView Earnings Details
5/1/2015Q115$1.08$1.14$35.93 billion$36.30 billionViewN/AView Earnings Details
2/10/2015Q414$1.20$1.21$36.06 billion$37.06 billionViewN/AView Earnings Details
11/4/2014Q314$1.13$1.15$34.74 billion$35.00 billionViewN/AView Earnings Details
8/5/2014Q214$1.10$1.13$33.47 billion$34.60 billionViewN/AView Earnings Details
5/2/2014Q114$1.05$1.02$32.31 billion$32.70 billionViewN/AView Earnings Details
2/11/2014Q413$1.11$1.12$32.67 million$32.80 millionViewN/AView Earnings Details
11/5/2013Q313$1.02$1.05$31.53 billion$32.00 billionViewListenView Earnings Details
8/6/2013Q2 2013$0.96$0.97$31.13 billion$31.25 billionViewListenView Earnings Details
5/1/2013Q113$0.79$0.83$30.36 billion$30.76 billionViewListenView Earnings Details
2/6/2013Q4 2012$1.10$1.14$31.13 billion$31.40 billionViewListenView Earnings Details
11/6/2012Q312$0.84$0.85$30.09 billion$30.23 billionViewN/AView Earnings Details
8/7/2012$0.80$0.81ViewN/AView Earnings Details
5/2/2012$0.63$0.65ViewN/AView Earnings Details
11/3/2011$0.68$0.70ViewN/AView Earnings Details
8/4/2011$0.65$0.65ViewN/AView Earnings Details
5/5/2011$0.55$0.57ViewN/AView Earnings Details
2/3/2011$0.79$0.80ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for CVS Health Corporation (NYSE:CVS)
Current Year EPS Consensus Estimate: $5.87 EPS
Next Year EPS Consensus Estimate: $6.58 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165$1.15$1.19$1.17
Q2 20166$1.30$1.36$1.31
Q3 20165$1.56$1.58$1.57
Q4 20165$1.77$1.80$1.79
Q1 20173$1.33$1.34$1.34
Q2 20173$1.48$1.59$1.52
Q3 20173$1.71$1.75$1.73
Q4 20173$1.91$2.00$1.97
Q1 20181$1.49$1.49$1.49
Q2 20181$1.62$1.62$1.62
(Data provided by Zacks Investment Research)


Current Dividend Information for CVS Health Corporation (NYSE:CVS)
Annual Dividend:$1.70
Dividend Yield:1.88%
Dividend Growth:29.10% (3 Year Average)
Payout Ratio:39.08% (Based on Trailing 12 Months of Earnings)
28.96% (Based on Current Year Consensus EPS Estimate)
25.84% (Based on Next Year Consensus EPS Estimate)
Track Record:8 Years of Consecutive Dividend Growth

Dividend History for CVS Health Corporation (NYSE:CVS)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for CVS Health Corporation (NYSE:CVS)
Insider Ownership Percentage: 0.58%
Institutional Ownership Percentage: 80.96%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/5/2016Larry J MerloCEOSell38,247$105.00$4,015,935.00View SEC Filing  
5/5/2016Troyen A BrennanEVPSell7,517$105.00$789,285.00View SEC Filing  
4/1/2016Stephen J GoldEVPSell21,922$105.00$2,301,810.00View SEC Filing  
3/9/2016Larry J MerloCEOSell38,247$100.00$3,824,700.00View SEC Filing  
2/11/2016Jonathan C. RobertsEVPSell23,355$92.86$2,168,745.30View SEC Filing  
2/1/2016Larry J. MerloCEOSell46,393$96.14$4,460,223.02View SEC Filing  
1/11/2016Larry J. MerloCEOSell46,393$95.00$4,407,335.00View SEC Filing  
10/27/2015Troyen A. BrennanEVPSell23,603$105.00$2,478,315.00View SEC Filing  
7/20/2015Eva C BorattoSVPSell22,107$110.34$2,439,286.38View SEC Filing  
7/15/2015Lisa BisacciaEVPSell49,908$110.00$5,489,880.00View SEC Filing  
6/1/2015C David Brown IIDirectorSell10,000$102.57$1,025,700.00View SEC Filing  
5/1/2015C David Brown IIDirectorSell15,000$100.27$1,504,050.00View SEC Filing  
4/10/2015Andrew SussmanEVPSell17,638$102.38$1,805,778.44View SEC Filing  
4/2/2015Troyen A BrennanEVPSell33,384$102.48$3,421,192.32View SEC Filing  
3/23/2015Troyen A BrennanEVPSell33,274$104.94$3,491,773.56View SEC Filing  
3/20/2015C David Brown IIDirectorSell25,000$104.30$2,607,500.00View SEC Filing  
1/7/2015Jonathan C RobertsEVPSell86,487$95.31$8,243,075.97View SEC Filing  
1/5/2015Larry J MerloCEOSell144,144$94.30$13,592,779.20View SEC Filing  
1/2/2015Andrew SussmanSVPSell4,220$95.67$403,727.40View SEC Filing  
1/2/2015Per Gh LofbergEVPSell347,343$95.28$33,094,841.04View SEC Filing  
11/7/2014Helena FoulkesEVPSell46,325$88.06$4,079,379.50View SEC Filing  
10/27/2014Lisa BisacciaSVPSell33,507$85.00$2,848,095.00View SEC Filing  
9/2/2014Andrew SussmanSVPSell9,020$79.45$716,639.00View SEC Filing  
8/6/2014J. David JoynerEVPSell123,516$76.10$9,399,567.60View SEC Filing  
7/21/2014Eva C BorattoSVPSell22,107$76.77$1,697,154.39View SEC Filing  
7/1/2014David M DentonCFOSell74,989$75.88$5,690,165.32View SEC Filing  
4/2/2014Eva BorattoSVPSell17,108$74.51$1,274,717.08View SEC Filing  
3/31/2014Troyen BrennanEVPSell18,867$74.33$1,402,384.11View SEC Filing  
1/3/2014David DentonCFOSell14,113$70.50$994,966.50View SEC Filing  
1/3/2014Per Gh LofbergEVPSell790,888$70.54$55,789,239.52View SEC Filing  
1/2/2014Jonathan RobertsEVPSell162,192$70.61$11,452,377.12View SEC Filing  
1/2/2014Larry MerloCEOSell228,875$70.76$16,195,195.00View SEC Filing  
12/10/2013Lisa BisacciaSVPSell12,057$68.00$819,876.00View SEC Filing  
11/18/2013Troyen BrennanEVPSell35,387$65.61$2,321,741.07View SEC Filing  
10/18/2013Eva C BorattoSVPSell11,053$60.50$668,706.50View SEC Filing  
10/11/2013Eva BorattoSVPSell11,053$59.50$657,653.50View SEC Filing  
9/13/2013Helena FoulkesEVPSell53,546$60.00$3,212,760.00View SEC Filing  
9/9/2013Helena FoulkesEVPSell47,568$58.65$2,789,863.20View SEC Filing  
9/4/2013Andrew SussmanSVPSell9,020$58.36$526,407.20View SEC Filing  
10/4/2012Andrew SussmanSVPSell9,020$49.00$441,980.00View SEC Filing  
10/1/2012Thomas M MoriartyEVPBuy6,164$48.67$300,001.88View SEC Filing  
9/13/2012David M DentonCFOSell11,526$47.00$541,722.00View SEC Filing  
8/21/2012Jean Pierre MillonDirectorSell33,726$45.73$1,542,289.98View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for CVS Health Corporation (NYSE:CVS)
News IconMix Cap Volatile Mover- CVS Health Corporation (NYSE:CVS), Celgene Corporation (NASDAQ:CELG) - Street Wise Report (press release) (blog) (NYSE:CVS) - September 27 at 4:29 PM
News Icon13F Action: Cvs Health Corporation (CVS) Shareholder Holland Capital Management LLC Increased Stake by $9.53 ... - Chester News (NYSE:CVS) - September 27 at 4:29 PM
News IconConsolidated Tomoka Land Acquires CVS Ground Lease in Dallas (NYSE:CVS) - September 27 at 9:06 AM
News IconTop Gainers of the Day: CVS Health Corporation (NYSE:CVS) from Health Care Plans (NYSE:CVS) - September 27 at 9:05 AM logoBiosimilars in Limelight on FDA Approval of Amgen Drug (NYSE:CVS) - September 27 at 9:05 AM logoCVS Health Corporation (NYSE:CVS) Accounts Payable At $7351 - (NYSE:CVS) - September 26 at 4:41 PM logoJim Cramer On CVS Health Corp And Skechers USA Inc (NYSE:CVS) - September 25 at 4:06 PM
News IconHealth Care Plans: CVS Health Corporation (NYSE:CVS) Position of the day (NYSE:CVS) - September 24 at 9:12 AM
News IconCVS Health Corporation (CVS) Upgrades/Downgrades Update - Newburgh Press (NYSE:CVS) - September 23 at 4:19 PM
News IconCVS Health Corporation declares quarterly dividend of $0.425 (42.5 cents) per share (NYSE:CVS) - September 23 at 9:36 AM logoRite Aid's (RAD) Q2 Earnings in Line, Sales Miss Estimates (NYSE:CVS) - September 23 at 9:36 AM
News IconCVS Health approves quarterly dividend (NYSE:CVS) - September 22 at 4:39 PM logoWith Shares Trading up at $90.30 (CVS) CVS Health Corporation Announces… (NYSE:CVS) - September 22 at 4:39 PM logoCVS Health Corporation Announces Quarterly Dividend (NYSE:CVS) - September 22 at 4:39 PM logoWill CVS Health (CVS) Stock Be Hurt by Delayed Curbside Service? (NYSE:CVS) - September 22 at 4:39 PM logo[$$] Discount Cosmetics Firm E.l.f. Soars in Stock Market Debut (NYSE:CVS) - September 22 at 4:39 PM logoGoldman: Stocks to Buy, Whoever Wins the Election (CVS, NOC) (NYSE:CVS) - September 22 at 4:39 PM logoCVS Health : The First Tobacco-Free Generation Is Within Reach (NYSE:CVS) - September 22 at 10:03 AM logoDoes IRS Exelon Win Threaten Triple Net 1031 Deals? (NYSE:CVS) - September 22 at 10:03 AM logoThe First Tobacco-Free Generation Is Within Reach (NYSE:CVS) - September 22 at 10:03 AM logoNew Setback for Sanofi's Lantus Increases Need for M&A (NYSE:CVS) - September 22 at 10:03 AM
News IconLeading stocks in today’s market: CVS Health Corporation (NYSE:CVS) (NYSE:CVS) - September 21 at 5:02 PM logoLook-Term Growth Looks Secure For CVS Health - Seeking Alpha - Seeking Alpha (NYSE:CVS) - September 21 at 8:44 AM logo[$$] CVS Catalysts Will Revive Stock (NYSE:CVS) - September 21 at 8:44 AM
News IconHC Stocks in the Rumor! CVS Health Corp (CVS), Gilead Sciences ... - share market updates (press release) (NYSE:CVS) - September 20 at 8:09 AM logoLong-Term Growth Looks Secure For CVS Health - Seeking Alpha (NYSE:CVS) - September 20 at 8:09 AM
News IconHigh Market Cap Stock of the Day – CVS Health Corporation (NYSE:CVS) (NYSE:CVS) - September 19 at 3:22 PM logoCVS Health : Expands Youth Drug Abuse Prevention Efforts for the 2016-2017 School Year (NYSE:CVS) - September 19 at 9:11 AM logoCVS Health Expands Youth Drug Abuse Prevention Efforts for the 2016-2017 School Year (NYSE:CVS) - September 19 at 9:11 AM logoJune 2017 Options Now Available For CVS Health (CVS) (NYSE:CVS) - September 16 at 4:25 PM
News IconShares of Alibaba Group Holding Ltd (NYSE:BABA) & CVS Health Corp (NYSE:CVS) Stocks News Update: Thursday (NYSE:CVS) - September 16 at 4:25 PM logo3 Best Defensive Stocks to Buy in 2016 (NYSE:CVS) - September 16 at 4:25 PM logoCVS Pharmacy Is Nearing Its 1-Year Low (NYSE:CVS) - September 16 at 4:25 PM logoJune 2017 Options Now Available For CVS Health (CVS) - Forbes (NYSE:CVS) - September 15 at 4:53 PM
News IconHC Stocks Reports Analysis= Northwest Biotherapeutics, Inc (NWBO), CVS Health Corp (NYSE:CVS) - share market updates (press release) (NYSE:CVS) - September 15 at 8:53 AM logoCVS Health's ScriptSync® Service Marks One Year Anniversary (NYSE:CVS) - September 15 at 8:53 AM logoCVS Health Makes Overdose-Reversal Drug Available Without A Prescription At All CVS Pharmacy Locations in Washington (NYSE:CVS) - September 15 at 8:53 AM logoBringing Health Screenings to Underserved Communities (NYSE:CVS) - September 14 at 9:44 PM
News IconStocks Charging Up for Historic Highs: CVS Health Corporation (NYSE:CVS), St. Jude Medical (NYSE:STJ) - Street Wise Report (press release) (blog) (NYSE:CVS) - September 14 at 4:35 PM logo3 Things You Should Know About the Healthcare Sector (NYSE:CVS) - September 13 at 9:20 AM
News IconCVS Health Corporation (NYSE:CVS) from Health Care Plans – Todays Top Gains (NYSE:CVS) - September 12 at 4:17 PM
News IconBlue-chip stocks of the day: CVS Health Corporation (NYSE:CVS) (NYSE:CVS) - September 12 at 4:17 PM logoWal-Mart’s market share gain in grocery is Target’s loss, analysts say (NYSE:CVS) - September 12 at 4:17 PM logoCVS Health Announces National Support of YMCA of the USA Diabetes Prevention Program and LIVESTRONG Foundation Initiatives (NYSE:CVS) - September 12 at 9:24 AM
News IconCVS, Walgreens rival, plans foothold in Colorado Springs (NYSE:CVS) - September 10 at 4:16 PM
News IconA Closer Look At Progressive Care Inc (OTCMKTS: RXMD) (NYSE:CVS) - September 9 at 4:23 PM logoCVS Health : Increasing Access to Health Care with Annual Project Health Campaign (NYSE:CVS) - September 9 at 4:23 PM logoRecent Buy: CVS Health (NYSE:CVS) - September 9 at 4:23 PM logoNew Update Spurs Renewed Hope On Rite Aid-Walgreens Deal (NYSE:CVS) - September 9 at 4:23 PM logoWhy Walgreens Is a Long-Term Buy Now (NYSE:CVS) - September 9 at 4:23 PM


CVS Health Corporation (NYSE:CVS) Chart for Wednesday, September, 28, 2016

Last Updated on 9/28/2016 by Staff